References
- Hirabayashi Y, Saito S, Takeshita MW, Kodera T, Munakata Y, Ishii T, et al. Mononeuritis multiplex, protein-losing gastroenteropathy, and choroidopathy seen together in a case of systemic lupus erythematosus. Mod Rheumatol. 2003;13:265–9.
- Shin JK, Junk YH, Bae MN, Beak IW, Kim KJ, Cho CS. Successful treatment of protein-losing enteropathy due to AA amyloidosis with octreotide in a patient with rheumatoid arthritis. Mod Rheumatol. 2013;13:406–11.
- Yamashita H, Muto G, Hachiya R, Sugiyama H, Takahashi Y, Kaneko H, et al. A case of Sjögren’s syndrome complicated by protein-losing gastroenteropathy with unprecedented pulmonary interstitial lesions. Mod Rheumatol. 2014;24:877–9.
- Izumi Y, Nakaoka K, Kamata M, Iwanaga N, Imadachi S, Kurohama H, et al. Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren’s syndrome successfully treated with mizoribine. Mod Rheumatol. 2016. doi:10.3109/14397595.2016.1145570.
- Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsuboi K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.
- Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16.
- Mok MY, Lau CS. Protein losing enteropathy and primary Sjögren's syndrome. Clin Exp Rheumatol. 1997;15:705–12.
- Nagashima T, Hoshino M, Shimoji S, Morino N, Kamimura T, Okazaki H, et al. Protein-losing gastroenteropathy associated with primary Sjögren’s syndrome: a characteristic orient variant. Rheumatol Int. 2009;29:817–20.
- Gupta A, Cohen NL, McCarthy S, McHugh JB, Kwon R. Protein-losing gastroenteropathy associated with Sjögren’s syndrome: first known case reported outside of Asia. ACGCR. 2015;2:184–6.
- Edworthy SM, Fritzler MJ, Keller JK, McHattie JD, Shatter EA. Protein losing enteropathy in systemic lupus erythematosus associated with intestinal lymphangiectasia. Am J Gastroenterol. 1990;85:1398–402.
- Uraoka Y, Tanigawa T, Watanabe K, Machida H, Okazaki H, Yamagami H, et al. Complete remission of protein-losing gastroenteropathy associated with Sjögren’s syndrome by B cell-targeted therapy with rituximab. Am J Gastroenterol. 2012;107:1266–8.
- Liao C-Y, Chien S-T, Wang C-C, Chiu H-W, Liu M-Y, Ben R-J, et al. Sjögren's syndrome associated with protein losing gastroenteropathy manifested by intestinal lymphangiectasia successfully treated with prednisolone and hydroxychloroquine. Lupus. 2015;24:1552–6.
- Guiraldes E. Protein-losing enteropathy. In: Wyllie R, Hyams JS, Kay M, editors. Pediatric Gastrointestinal and Liver Disease. 5th ed. Philadelphia: Elsevier; 2015. p. 389–94.